US · Healthcare · Medical Devices
EPS came in at -0.51 against a street estimate of -0.45 — a miss of 13.3%.
Analysts rate CeriBell, Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $28.00.
| Fund | Stake |
|---|---|
| FMR Inc | 12.64% |
| TPG GP A, LLC | 10.34% |
| Red Tree Management, LLC | 5.75% |
| BlackRock Inc | 4.72% |
| Bank of New York Mellon Corp | 3.02% |
| Vanguard Capital Management, LLC | 2.96% |
| KCM Capital Inc | 2.93% |
| Federated Hermes Inc | 2.45% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 CERIBELL, INC. — QUARTERLY REPORT SUMMARY Q2 2026 (Period ended June 30, 2026) --- HEADLINE NUMBERS • Total Revenue (6 months): $54.6 million (up 3 | 2026-08-10 |
| Results announced · Q3 2026 CERIBELL, INC. - Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue Q2 2026: $28.1 million, up 33% from $21.2 million in Q2 2025 • Product re | 2026-08-10 |
| Board / officer change · Q3 2026 CERIBELL, INC. - 8-K SUMMARY (July 28, 2026) BUSINESS & SEGMENT HIGHLIGHTS • CeriBell, Inc. (ticker: CBLL) is a Nasdaq-listed medical device company | 2026-07-30 |
| Shareholder vote results · Q2 2026 CERIBELL, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held June 2, 2026 • Company trades on Nasdaq Global Select Market under t | 2026-06-02 |
| Quarterly report · Q1 2026 CERIBELL, INC. – Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total revenue (Q1 2026): $26.5 million, up 29% from $20.5 million in Q1 2025 - Produ | 2026-05-11 |
| Results announced · Q2 2026 CERIBELL, INC. - Q1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Total revenue Q1 2026: $26.5 million — up 29% from $20.5 million in Q1 2025 • | 2026-05-11 |
| Proxy statement · Q2 2026 CERIBELL, INC. – 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of two Class II directors—Josef Parvizi, M.D., | 2026-04-20 |
| Annual report FY2025 CERIBELL, INC. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: CeriBell, Inc. (Nasdaq: CBLL), Delaware incorporation, IRS ID 47-1785 | 2026-02-24 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CeriBell, Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.